Back

A predictive model of pcsk-9 inhibitors eligibility in coronary and dyslipidemic patients

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Risk Factors and Prevention ePosters Lipids ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Ioanna DIMA

Hippokration General Hospital, Athens (Greece)

217 More presentations in this session

Presentation thumbnail
The association between napping and the risk of cardiovascular disease and all-cause mortality: a systematic review and dose-response meta-analysis
Doctor Z. Pan (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Prediction of 10-year and lifetime risk of cancer in individual patients with established cardiovascular disease, results from UCC-SMART and CANTOS
Miss C. van 't Klooster (Utrecht, NL)
Abstract Slides
Presentation thumbnail
Geographical profiles of cardiovascular risk and the risk factors in China: data from a nationwide population-based screening project
Assistant Professor C. Wu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Associations between life-course frailty and later-life heart size and function in the 1946 NSHD British birth cohort-an epidemiological study
Mr C. Topriceanu (London, GB)
Abstract Slides
Presentation thumbnail
Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions
Doctor P. Welsh (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Risk Factors and Prevention ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Webinar
Lipoprotein(a): a modifiable risk factor of atherosclerotic cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources